Inflammatory and prothrombotic biomarkers associated with the severity of COVID-19 infection
S Lopez-Castaneda… - Clinical and Applied …, 2021 - journals.sagepub.com
Among COVID-19 hospitalized patients, high incidence of alterations in inflammatory and
coagulation biomarkers correlates with a poor prognosis. Comorbidities such as chronic …
coagulation biomarkers correlates with a poor prognosis. Comorbidities such as chronic …
The relationship between inflammatory cytokines and coagulopathy in patients with COVID-19
Coronavirus disease 2019 (COVID-19), with a broad range of clinical and laboratory
findings, is currently the most prevalent medical challenge worldwide. In this disease …
findings, is currently the most prevalent medical challenge worldwide. In this disease …
The most important biomarker associated with coagulation and inflammation among COVID-19 patients
LZ Hong, ZX Shou, DM Zheng, X Jin - Molecular and Cellular Biochemistry, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) induced by SARS-Cov-2 can be related to
coagulopathy. Also, the infection-induced inflammatory changes are found in patients with …
coagulopathy. Also, the infection-induced inflammatory changes are found in patients with …
[HTML][HTML] Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
FA von Meijenfeldt, S Havervall, J Adelmeijer… - Research and practice …, 2021 - Elsevier
Abstract Background and Aims Patients with severe coronavirus disease 2019 (COVID‐19)
are at significant risk of thrombotic complications. However, their prothrombotic state is …
are at significant risk of thrombotic complications. However, their prothrombotic state is …
Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy
R Cacciola, E Gentilini Cacciola, V Vecchio… - Journal of Thrombosis …, 2022 - Springer
Abstract Introduction Coronavirus 2 (CoV-2) infection or coronavirus disease 2019 (COVID-
19) is frequently associated with microvascular thrombosis. The microthrombosis in COVID …
19) is frequently associated with microvascular thrombosis. The microthrombosis in COVID …
Systemic inflammatory response syndrome is a major contributor to COVID-19–associated coagulopathy: insights from a prospective, single-center cohort study
P Masi, G Hékimian, M Lejeune, J Chommeloux… - Circulation, 2020 - Am Heart Assoc
CORRESPONDENCE plasminogen activator and PAI-1 (plasminogen activator inhibitor-1)
antigen levels were increased in both groups, with significantly higher tissue plasminogen …
antigen levels were increased in both groups, with significantly higher tissue plasminogen …
Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients
D Cabrera-Garcia, A Miltiades, P Yim… - International Journal of …, 2022 - Springer
Abstract Severe coronavirus disease-19 (COVID-19) has been associated with fibrin-
mediated hypercoagulability and thromboembolic complications. To evaluate potential …
mediated hypercoagulability and thromboembolic complications. To evaluate potential …
[HTML][HTML] Thromboinflammatory biomarkers in COVID-19: systematic review and meta-analysis of 17,052 patients
Objective To evaluate differences in thromboinflammatory biomarkers between patients with
severe coronavirus disease 2019 (COVID-19) infection/death and mild infection. Patients …
severe coronavirus disease 2019 (COVID-19) infection/death and mild infection. Patients …
[HTML][HTML] Comparison of the coagulopathies associated with COVID‐19 and sepsis
Abstract Background Coronavirus disease 2019 (COVID‐19) is associated with activation of
coagulation that mainly presents as thrombosis. Sepsis is also associated with activation of …
coagulation that mainly presents as thrombosis. Sepsis is also associated with activation of …
[HTML][HTML] Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID‐19
A Rauch, J Labreuche, F Lassalle, J Goutay… - Journal of Thrombosis …, 2020 - Elsevier
Background Hypercoagulability seems to contribute to SARS‐CoV‐2 pneumonia
pathogenesis. However, age and metabolic syndrome are potential confounders when …
pathogenesis. However, age and metabolic syndrome are potential confounders when …